SCHEMBL3345343

SCHEMBL3345343

O=C(O)c1ccsc1C(F)(F)F

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.43
KDM4E B2RXH2 2/20 0.43
HPGD P15428 2/20 0.43
MAPK1 P28482 2/20 0.43
GLA P06280 2/20 0.43
GAA P10253 1/20 0.43
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
MAPT P10636 2/20 0.43
PTPN2 P17706 1/20 0.43
PTPRB P23467 1/20 0.43
PTPN6 P29350 1/20 0.43
POLB P06746 1/20 0.43
NR4A1 P22736 1/20 0.43
RECQL P46063 1/20 0.43
ESR2 Q92731 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
HSD17B10 Q99714 2/20 0.39
DAO P14920 1/20 0.38
ACLY P53396 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11185194 0.84 ALDH1A1 (0.41) ALDH1A1KDM4EHPGDMAPK1GLA
SCHEMBL3919799 0.82 ALDH1A1 (0.36) ALDH1A1KDM4EHPGDMAPK1GLA
SCHEMBL21128646 0.79 ALDH1A1 (0.51) ALDH1A1KDM4EHPGDMAPK1GLA
SCHEMBL22468394 0.78 ALDH1A1 (0.50) ALDH1A1KDM4EHPGDMAPK1GLA
SCHEMBL11192364 0.77 ALDH1A1 (0.40) ALDH1A1KDM4EHPGDMAPK1GLA
SCHEMBL13898734 0.76 DHODH (0.51) ALDH1A1KDM4EHPGDMEN1KMT2A
SCHEMBL6384779 0.75 ALDH1A1 (0.35) ALDH1A1KDM4EHPGDMAPK1GLA
SCHEMBL21971963 0.73 KDM4E (0.46) ALDH1A1KDM4EHPGDMAPK1GLA
SCHEMBL25308960 0.72 CTNNB1 (0.38) ALDH1A1HPGDGAAMEN1KMT2A
SCHEMBL28483930 0.72 ALDH1A1 (0.45) ALDH1A1KDM4EHPGDMAPK1GLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102202505-A Method for improving plant health BASF SE 2011-09-28 CN claimed
WO-2010049405-A1 METHOD FOR IMPROVING PLANT HEALTH BASF SE (DE) 2010-05-06 WO claimed
CN-106414434-B Isothiazole derivatives as GPR120 agonists for the treatment of type II diabetes 詹森药业有限公司 2019-12-31 CN disclosed
CN-108938625-A Purposes and preparation method of the 2- virtue formamido thiophene -3- carboxylic acid derivative as ANO1 protein inhibitor 北京大学 2018-12-07 CN disclosed
CN-102202505-A Method for improving plant health BASF SE 2011-09-28 CN disclosed
WO-2010049405-A1 METHOD FOR IMPROVING PLANT HEALTH BASF SE (DE) 2010-05-06 WO disclosed
US-7501530-B2 Trifluoromethyl-thiophene carboxylic acid aniledes and use thereof as fungicides BASF AKTIENGESELLSCHAFT (DE) 2009-03-10 US disclosed
US-20060172891-A1 Trifluoromethyl-thiophene carboxylic acid aniledes and use thereof as fungicides BASF AKTIENGESELLSCHAFT (DE) 2006-08-03 US disclosed
CN-1764657-A Trifluoromethyl-thiophene carboxylic acid anilides and use thereof as fungicides. BASF AG (DE) 2006-04-26 CN disclosed
EP-1608637-A1 TRIFLUOROMETHYL-THIOPHENE CARBOXYLIC ACID ANILIDES AND USE THEREOF AS FUNGICIDES BASF AKTIENGESELLSCHAFT (DE) 2005-12-28 EP disclosed
WO-2004085419-A1 TRIFLUOROMETHYL-THIOPHENE CARBOXYLIC ACID ANILIDES AND USE THEREOF AS FUNGICIDES BASF AKTIENGESELLSCHAFT (DE) 2004-10-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060172891-A1 Trifluoromethyl-thiophene carboxylic acid aniledes and use thereof as fungicides AS3MT, GABBR1, TH ALDH1A1 257/4885KDM4E 273/4885HPGD 4736/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.